The effects of betaxolol hydrochloride ophthalmic solution on intraocular pressures during transient microgravity

Aviation Space and Environmental Medicine

Volumn 70, Issue 10, 1999, Pages 1012-1017

  Pattinson, Terrence J ^a,b   Gibson, Charles R ^b   Manuel, Francis K ^b   Bishop, Sheryl L ^c   March, Wayne F ^c  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b NASA JOHNSON SPACE CENTER   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Betaxolol; Glaucoma; Weightlessness; Weightlessness simulation

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FLIGHT; HUMAN; INTRAOCULAR PRESSURE; MICROGRAVITY; PRESSURE MEASUREMENT; TONOMETRY; WEIGHTLESSNESS;

FLIGHT EXPERIMENT; MANNED; PARABOLIC FLIGHT; SHORT DURATION;

ADAPTATION, PHYSIOLOGICAL; ADRENERGIC BETA-ANTAGONISTS; ADULT; BETAXOLOL; DOUBLE-BLIND METHOD; HUMANS; INTRAOCULAR PRESSURE; MIDDLE AGED; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; PILOT PROJECTS; PROSPECTIVE STUDIES; SPACE FLIGHT; TONOMETRY, OCULAR; UNITED STATES; UNITED STATES NATIONAL AERONAUTICS AND SPACE ADMINISTRATION; WEIGHTLESSNESS;

EID: 0033373841     PISSN: 00956562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Bass L, Constantine V. Pigmentary dispersion syndrome and suspected low tension pigmentary glaucoma. J Am Optom Assoc 1998; 59:630-4.
2. Camras C, Wax M, Ritch R, et al. Latanoprost treatment for glaucoma: effects of treating for 1 year and of switching from timolol. United States Latanoprost Study Group. Am J Ophthalmol 1998; 126:390-9.
3. Collignon N, Collignon-Brach J. Effect of topical beta blockers on human retinal vessels diameters. Int Ophthalmol 1997-98; 21: 199-203.
4. Draeger J, Schwartz R, Groenhoff S, Stern C. Self-tonometry under microgravity conditions. Aviat Space Environ Med 1995; 66:568-70.
5. Drance S. Disc hemorrhages in the glaucomas. Surv Ophthalmol 1989; 33:331-7.
6. Harris A, Spaeth G, Sergott R, Katz L, Cantor L, Martin B. Retrobulbar arterial hemodynamic effects of betaxolol and timolol in normal tension glaucoma. Am J Ophthalmol 1995; 120:168-75.
7. Hessemer V, Rossler R, Jacobi K. Tono-pen, a new tonometer. Int Ophthalmol 1989; 13:51-6.
8. Kao S, Lichter P, Bergstrom T, et al. Clinical comparison of the oculab tono-pen to the goldman aplanation tonometer. Ophthalmology 1987; 94:1541-4.
9. Kuzmin M. Retinal vessel reactions and intraocular tension in humans staying in a horizontal position for 120 days. Kosmicheskaia Biologiia i Meditsina 1973; 7:65-9.
10. Linder B, Tick G, Wolf M. Altering body position affects intraocular pressure and visual function. Invest Ophthalmol Vis Sci 1988; 29:1492-7.
11. Linder B, Trick G. Simulation of space flight with whole body head down tilt -influence on intraocular pressure and retino-cortical processing. Aviat Space Environ Med 1987; 58:A139-42.
12. Mader T, Gibson C, Caputo M, Hunter N. Intraocular pressure and retinal vascular changes during transient exposure to microgravity. Am J Ophthalmol 1993; 115:347-50.
13. Mader T, Taylor G, Charles J, et al. Intraocular Pressure. EDOMP Status Report STS-42 through STS-52. Washington, DC: NASA; 67:August, 1993; DSO 472.
14. Mader T, Taylor G, Hunter N, Caputo M. Intraocular pressure, retinal vascular, and visual acuity changes during 46 hours of 10 degree head down tilt. Aviat Space Environ Med 1990; 61:810-3.
15. Mader T. Intraocular pressures in microgravity. J Clin Pharmacol 1991; 31:947-50.
16. Moore C, Milne S, Morrison J. Noninvasive measurement of intraocular pressure with the TonoPen. Invest Ophthalmol Vis Sci 1993; 3 4:363-9.
17. Schadlu R, Maus T, Nau C, Brubaker R. Comparison of the efficacy of apraclonidine and brimonidine as aqueous suppressants in humans. Arch Ophthalmol 1998; 116:1441-4.
18. Schwartz R, Draeger J, Groenhoff S, Flade K. Results of self-tonometry during the first German-Russian MIR mission 1992. Ophthalmologie 1993; 90:640-2.
19. Serle J. A comparison of the safety and efficacy of twice daily brimonidine 0.2% versus betaxolol 0.25% in subjects with elevated intraocular pressure. The brimonidine study group 111. Surv Ophthalmol 1996; 42 Suppl 1:S39-47.
20. Sorensen S, Abel S. Comparison of the ocular beta-blockers. Ann Pharmacother 1996; 30:43-54.
21. Stewart W, Garrison P. Beta Mocker induced complications and the patient with glaucoma. Newer treatments to help reduce systemic adverse events. Arch Intern Med 1998; 158: 221-6.
22. Strahlman E, Tipping R, Vogel R. A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. International Dorzolamide Study Group. Arch Ophthalmol 1995; 113:985-6.
23. Yu D, Su E, Cringle S, et al. Effect of betaxolol, tirnolol and nimodipine on human and pig retinal arterioles. Exp Eye Res 1998; 67:73-83.